000 | 01776 a2200433 4500 | ||
---|---|---|---|
005 | 20250516132006.0 | ||
264 | 0 | _c20140204 | |
008 | 201402s 0 0 eng d | ||
022 | _a1879-0712 | ||
024 | 7 |
_a10.1016/j.ejphar.2013.01.006 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAlSuleimani, Yousuf M | |
245 | 0 | 0 |
_aMechanisms of vasorelaxation induced by oleoylethanolamide in the rat small mesenteric artery. _h[electronic resource] |
260 |
_bEuropean journal of pharmacology _cFeb 2013 |
||
300 |
_a1-11 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aEndocannabinoids |
650 | 0 | 4 |
_aEndothelium, Vascular _xphysiology |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMesenteric Arteries _xphysiology |
650 | 0 | 4 |
_aNitric Oxide _xphysiology |
650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
650 | 0 | 4 |
_aOleic Acids _xpharmacology |
650 | 0 | 4 |
_aPhosphotransferases (Alcohol Group Acceptor) _xantagonists & inhibitors |
650 | 0 | 4 |
_aPotassium Channels, Calcium-Activated _xantagonists & inhibitors |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aReceptor, Cannabinoid, CB1 _xantagonists & inhibitors |
650 | 0 | 4 |
_aReceptor, Cannabinoid, CB2 _xantagonists & inhibitors |
650 | 0 | 4 |
_aTRPV Cation Channels _xantagonists & inhibitors |
650 | 0 | 4 |
_aType C Phospholipases _xantagonists & inhibitors |
650 | 0 | 4 |
_aVasodilation _xdrug effects |
650 | 0 | 4 |
_arho-Associated Kinases _xantagonists & inhibitors |
700 | 1 | _aHiley, C Robin | |
773 | 0 |
_tEuropean journal of pharmacology _gvol. 702 _gno. 1-3 _gp. 1-11 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejphar.2013.01.006 _zAvailable from publisher's website |
999 |
_c22438785 _d22438785 |